Premium
Role of Bone Morphogenetic Protein 2 Polymorphisms in Bone Mineral Density after the Start of Treatment with Atorvastatin
Author(s) -
UsateguiMartín Ricardo,
Vega Gemma,
AbadManteca Laura,
RuizMambrilla Marta,
CaleroPaniagua Ismael,
DueñasLaita Antonio,
PérezCastrillón José L.
Publication year - 2018
Publication title -
basic and clinical pharmacology and toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.805
H-Index - 90
eISSN - 1742-7843
pISSN - 1742-7835
DOI - 10.1111/bcpt.13086
Subject(s) - runx2 , endochondral ossification , mevalonate pathway , osteoblast , chemistry , bone resorption , medicine , bone morphogenetic protein 2 , endocrinology , bone growth , bone morphogenetic protein , bone mineral , fluvastatin , osteoporosis , reductase , biochemistry , anatomy , cartilage , simvastatin , enzyme , gene , in vitro
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom